Showing results (301-310 of 985) with videos related to
Sort By:
Pageof 99
Journal of Cardiac Failure|July 16, 2022
Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?Rida Shahid, W H Wilson Tang, Allan L Klein, et al.Current Treatment Options in Cardiovascular Medicine|April 28, 2025
Next-Generation Cardiac Magnetic Resonance Imaging Techniques for Characterization of Myocardial DiseaseJulia Simkowski, Brendan Eck, W H Wilson Tang, et al.Acta Psychiatrica Scandinavica|March 1, 1981
Catecholamines and monoamine oxidase activity in anxietyR J Mathew, B T Ho, P Kralik, et al.Journal of Cardiac Failure|January 1, 2013
A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF)Nancy M Albert, Benjamin Nutter, Jennifer Forney, et al.Pharmacotherapy|January 1, 1983
A double-blind clinical trial of mianserin versus amitriptyline: differentiation by adverse symptomatologyW Guy, J M McEvoy, T A Ban, et al.Journal of Cardiac Failure|September 13, 2025
Evolving Natural History of Left Ventricular Ejection Fraction Recovery and Relapse in Heart Failure With Reduced Ejection FractionNandan Kodur, Paul Gunsalus, Alex Milinovich, et al.European Journal of Heart Failure|February 20, 2025
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosisJoshua Longinow, Saeid Mirzai, Po-Hao Chen, et al.Heart Failure Reviews|July 29, 2024
Management of patients with heart failure and chronic kidney diseaseLingling Wu, Mario Rodriguez, Karim El Hachem, et al.The Journal of Clinical Psychiatry|January 1, 1983
Somatic symptoms in depression and antidepressantsR J Mathew, M L Weinman, R Thapar, et al.International Pharmacopsychiatry|January 1, 1980
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical studyW M Petrie, J P McEvoy, W H Wilson, et al.Pageof 99